Applicant, as named in the Orange Book

Jazz Pharms Inc

Next listed expiry: Defitelio on 22 Jun 2032. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Defitelio defibrotide sodium	defibrotide sodium	208114	22 Jun 2032	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.